• CERAHEAD-F

    Symptomatic treatment of vertigo. Elderly suffering from loss of memory, vertigo, lack of concentration or alertness, changes of mood, deterioration in behaviour, personal negligence, dementia…
  • ZAPNEX-5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • SERNAL

    The acute and maintenance treatment of schizophrenia (both negative and positive symptoms). When deciding to use long-term risperidon, it should periodically re-evaluate the effectiveness of…
  • NILKEY

    Acute and maintenance treatment of Major Depressive Disorder. Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD). Acute and…
  • MANZURA-7.5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • MANZURA-5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • MANZURA-15

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • LEVETRAL-750

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • LEVETRAL

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • KEIKAI

    Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only…
  • KAUSKAS-50

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…
  • KAUSKAS-200

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…